c-met role as biomarker and player in innate and acquired resistance in non-small-cell lung cancer
Published 4 years ago • 424 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
49:54
practical principles of biomarker testing in advanced non-small cell lung cancer
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
5:50
how is biomarker testing carried out?
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
22:25
biomarkers in nsclc | episode 3 | med table talk™ non-small cell lung cancer series
-
2:01
dr. rimm on biomarker testing in lung cancer
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
2:07
predictive biomarkers for immunotherapy in non-small cell lung cancer
-
1:54
dr. yorio on searching for biomarkers in metastatic lung cancer
-
4:02
current and future biomarker testing in lung cancer
-
14:00
berkeley pharma tech presents non small cell lung cancer: prognostic biomarkers
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
1:04
ros1 biomarkers and lung cancer
-
5:27
what are biomarkers? (cancer treatment options)
-
0:30
revolutionizing lung cancer treatment using biomarkers
-
8:52
multiplex ihc as biomarkers for cancer immunotherapy
-
24:37
urine as promising biomarker source for cancer detection